Evidence map›Paper›PMID 33935760›Full record

ArticleFrontiers in pharmacology2021

Cardiac Protection by Oral Sodium Thiosulfate in a Rat Model of L-NNA-Induced Heart Disease.

Isabel T N Nguyen, Lucas M Wiggenhauser, Marian Bulthuis, Jan-Luuk Hillebrands, Martin Feelisch, Marianne C Verhaar, Harry van Goor, Jaap A Joles

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. HBiomolecules · 2022
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Isabel T N NguyenDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, Netherlands.
Lucas M WiggenhauserDepartment of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands.
Marian BulthuisDepartment of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands.
Jan-Luuk HillebrandsDepartment of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands.
Martin FeelischClinical and Experimental Sciences, Faculty of Medicine, Southampton General Hospital and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
Marianne C VerhaarDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, Netherlands.
Harry van GoorDepartment of Pathology and Medical Biology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands.
Jaap A JolesDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, Netherlands.
University Medical Center Utrecht · NLUniversity Medical Center Groningen · NLUniversity of Groningen · NLUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension contributes to cardiac damage and remodeling. Despite the availability of renin-angiotensin system inhibitors and other antihypertensive therapies, some patients still develop heart failure. Novel therapeutic approaches are required that are effective and without major adverse effects. Sodium Thiosulfate (STS), a reversible oxidation product of hydrogen sulfide (H

Indexed as

ACE-inhibitorcardiovascular diseasehydrogen sulfidehypertensionnitric oxide

Identifiers

PMID33935760
PMCPMC8082682
OpenAlexW3153834136

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.